Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14356/1231
Title: Post COVID-19 vaccine Guillain-Barré syndrome
Authors: khadka, Bikash
Khanal, Kishor
Citation: khadkaB., & KhanalK. (2022). Post COVID-19 vaccine Guillain-Barré syndrome. Journal of Nepal Health Research Council, 19(04), 852-854. https://doi.org/10.33314/jnhrc.v19i04.3803
Issue Date: 2021
Publisher: Nepal Health Research Council
Article Type: Case Report
Keywords: Guillain-Barré syndrome
immunoglobulin
jansen vaccine
polyneuropathy
Series/Report no.: Oct-Dec, 2021;3803
Abstract: Abstract Guillain-Barré syndrome is an acute generalized polyneuropathy which usually follows infection with a virus or bacteria, although rarely vaccination may be associated with it. We present a case of a 44-year-man who presented with progressive weakness of both lower limbs since 6?days, neurological examination findings were consistent with flaccid-type paraplegia and investigation findings including lumbar puncture and nerve conduction studies were consistent with the diagnosis of Guillain-Barré syndrome. He had received the Johnson and Johnson corona virus disease-19 vaccine intramuscularly 15 days before his presentation. Only potential triggering factor in this case was positive finding of Jansen Vaccine. Keywords: Guillain-Barré syndrome; immunoglobulin; jansen vaccine; polyneuropathy.
Description: Case Report
URI: http://103.69.126.140:8080/handle/20.500.14356/1231
ISSN: Print ISSN: 1727-5482; Online ISSN: 1999-6217
Appears in Collections:Vol. 19 No. 04 (2021): Vol 19 No 4 Issue 53 Oct-Dec 2021

Files in This Item:
File Description SizeFormat 
3803-Manuscript-26809-1-10-20220313.pdfFulltext Download478.18 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.